Harnessing the Immune System to fight cancer

Takis main focus is the development of therapeutic cancer vaccines against tumor antigens which play a role in tumor development and maintenance.

Our team
is recognized

for the conception and implementation of a number of innovative technologies with the goal to improve in vivo gene transfer, regulation of gene expression and immunogenicity.


Takis as a CRO provides a variety of research services

in the areas of Oncology, Immunology, Infectious Diseases and novel preclinical models.


Scientific Collaborations

eit HEALT - European Union

eit Health
Takis Biotech

Harnessing the Immune System to fight cancer.

Takis S.r.l.

Via Castel Romano, 100
00128 Rome - Italy
P. I.V.A. 10700711004

Follow us